H
HCM
Hutchmed (China) Limited
10.87
-0.30-2.69%After Hours: 10.94 +0.07 +0.63%18:30 06/05 EDT
OPEN/PREV CLOSE11.06/11.17
TODAY RANGE10.71-11.06
VOL120.95K
MARKET CAP1.90B
52 WEEK RANGE10.71-19.50
AVG VOL (3M)41.15K
% TURNOVER0.07%
TURNOVER--
P/E (TTM)4.153
% RANGE3.13%
EPS(TTM)2.617
P/E(FORWARD)121.97
P/B1.532
BVPS7.10
DIVIDEND--
P/S3.457
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.90B
SHARES OUTSTANDING174.47M
NEXT EARNINGS08/05-08/10
FREE FLOAT174.45M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·05/30 00:33
Morgan Stanley Reaffirms Their Hold Rating on HUTCHMED (China) (HCM)
TipRanks·05/28 21:09
Hutchmed upgraded to Equal Weight from Underweight at Morgan Stanley
TipRanks·05/27 16:30
Hutchmed’s New HER2 Trial Adds Early Stage Upside to Its Oncology Pipeline
TipRanks·05/23 00:38
UBS Reaffirms Their Buy Rating on HUTCHMED (China) (HCM)
TipRanks·05/21 10:10
Hutchmed, Innovent jointly announce NMPA approval for Elunate/Tyvyt combination
TipRanks·05/21 10:05
Hutchmed, Innovent Biologics announce China NMPA approval for NDA
PUBT·05/13 08:38
HUTCHMED files directors list with Hong Kong Stock Exchange
TipRanks·04/29 10:46
Hutchmed says NDA for sovleplenib accepted in China
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.